Dr. Khalid Al Sabti, a Kuwaiti Ophthalmologist graduated from Glasgow University (United Kingdom) in 1993. He did his post-graduate Ophthalmology training at McGill University in Canada (Fellowship of the royal college of physicians and surgeons of Canada) followed by Vitreoretinal fellowship at the same institute. After completing the residency and fellowship in year 2000 he joined Al Bahar Eye Hospital, the only government eye hospital in Kuwait as a retina specialist. He was then joined Kuwait University as an assistant professor. He became the chief of Vitreoretinal unit at al Bahar Hospital (Kuwait major Government Eye Hospital) in 2003. In 2006 he was granted a position of Associate professor at Kuwait University. His academic participation in research including several publications in peer reviewed journals with over 20 publications. He was appointed to be the chairman of Ophthalmology faculty at Kuwait institute of Higher Medical qualifications (KIMS) in 2005. He initiated Ophthalmology residency program in Kuwait in 2005. At this time the first group Ophthalmology residents has started the program for the first time in Kuwait.
Dr. Khalid participation in several international scientific meetings and conferences including AAO, ASRS, Euretina as well as local and regional conferences as a speaker. He was invited for live surgery for Floretina 2017/ 2019/2021/2022/2023/2024/2025, ASRS 2019.
His interest in Retina surgery and ocular Trauma as well as developing surgical instruments. He has 4 US patents for surgical instrument. He was invited for Vail Vitrectomy meeting in 2019 &2025 presenting his novel multiport vitrectomy cutter and Robotic Eye Surgery.
He is also the founder of Kuwait specialized eye center (KSEC), the first private Ophthalmology center in Kuwait providing a high standard of eye care to the people of Kuwait. The vision of this project is to be a prominent eye care provider in the region providing world class eye care, Eye Education and research.

Dr. Voraporn Chaikitmongkol received her medical degree in 2005 and ophthalmology degree in 2010 from Chiang Mai University, Thailand. Following her clinical vitreo-retinal fellowship training in 2011, she joined the faculty at the Department of Ophthalmology, Chiang Mai University. In 2012, Dr. Chaikitmongkol did her post-doctoral clinical research fellowship at the Wilmer Eye Institute, Johns Hopkins University School of Medicine (USA); medical retina training with Professor Neil M. Bressler and Professor Susan B. Bressler (2012-2014), and visual neurophysiology training with Professor Hendrik P.N. Scholl (2013-2014). Her research interest involves polypoidal choroidal vasculopathy, age-related macular degeneration, diabetic retinopathy, and novel retinal imaging modalities.
Dr. Chaikitmongkol has received the Japanese Ophthalmological Society International Young Investigator Award 2019 for her research titled “Color Fundus Photography, OCT, and Fluorescein Angiography in Diagnosing Polypoidal Choroidal Vasculopathy (Am J Ophthalmol 2018). Dr. Chaikitmongkol is an author of 65 international peer-reviewed papers, and a co-author of several book chapters including the AMD chapters of the most recent editions of Ryan’s Retina Textbook (7th edition) and the Albert and Jakobiec’s Principles and Practices of Ophthalmology (4th edition). Dr. Chaikitmongkol is currently an Associate Professor, and Program Director of Ophthalmology residency training at Chiang Mai University, Chiang Mai, Thailand.

Dr. Jay Chhablani is a Professor of Ophthalmology and Vitreo-Retinal Surgeon at the University of Pittsburgh, where he also serves as the Vice Chair, Clinical Research at the UPMC Vision Institute. He founded the Choroid Analysis and Research (CAR) Lab, which focuses on computational and biological research in choroidal diseases. His primary research interests include macular disorders, artificial intelligence, automated retinal image analysis, and advanced imaging techniques. Dr. Chhablani has received continuous research funding from the National Institutes of Health (NIH) and various foundations. He has authored over 700 peer-reviewed publications, predominantly in the field of choroid, and has edited key reference books such as Choroidal Disorders, Central Serous Chorioretinopathy, and Choroidal Neovascularization. He serves as a reviewer for high-impact journals, including Science Translational Medicine and The Lancet, and is on the editorial board of the American Journal of Ophthalmology and other leading journals. In addition to his academic contributions, Dr. Chhablani is a member of prestigious organizations such as the Macula Society and Gonin Club and serves on the scientific committees of national and international societies, including the American Academy of Ophthalmology. He has delivered over 250 invited lectures worldwide, held visiting professorships at multiple universities, and received numerous national and international awards, including several named lectureships.

Dr. Finn is currently Associate Professor of Ophthalmology and Retina fellowship director at the Vanderbilt Eye Institute in Nashville, Tennessee. Dr. Finn completed fellowship in medical and surgical diseases of the retina and vitreous at Duke University in Durham, North Carolina. During fellowship, she received the Ronald G. Michels Fellowship Foundation award, given to select outstanding fellows in vitreoretinal surgery. Dr. Finn is an active member of the American Academy of Ophthalmology, American Society of Retina Specialists, Vit-Buckle Society, Retina Society and Macula Society. She has published numerous original research articles on a wide variety of retinal diseases, including new techniques for macular hole surgery, the use of intraoperative OCT imaging, and biomarkers of atrophy and scar in macular degeneration. Dr. Finn has a strong interest in surgical innovation and retinal imaging analysis.

Professor Adrian Fung is Head of the Westmead Hospital Vitreoretinal Unit, Sydney, Australia. He is Clinical Professor, Macquarie University Hospital; Clinical Associate Professor at the University of Sydney, Australia and Adjunct Professor, Sun Yat-sen University, China. He has published 154 peer-reviewed journal articles and 7 book or book chapters and is the Chief and Founding Editor of the textbook www.vrsurgeryonline.com. He has been awarded the Asia Pacific Academy of Ophthalmology Distinguished Service and Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Federal Meritorius Service Awards. He is Co-Chair of the RANZCO Scientific Programme Committee, a RANZCO RACE examiner and sits on the ANZSRS Surgical Registry Committee. Professor Fung has been a Principal Investigator for multiple clinical trials and was the first surgeon outside of the USA to insert the Port Delivery System and amongst the first in the world to use the Alcon Unity Vitrectomy Platform. He is Editor for Retinal Cases and Brief Reports and Medical Retina Section Editor for Clinical and Experimental Ophthalmology. He is a member of the Macula Society, Retina Society, ASRS, AAO, ARVO, Euretina and APVRS. He is the Course Convenor for Ophthalmology Updates! (www.ophthalmologyupdates.com) and an APVRS Councillor.

Yi-Ting Hsieh, MD, PhD is Clinical Professor at National Taiwan University and Chair of Ophthalmology at NTU Hospital, Hsin-Chu Branch. His work bridges cutting-edge research and clinical care, focusing on diabetic retinopathy, vitreomacular interface diseases, age-related macular degeneration, hydroxychloroquine retinopathy, ocular imaging, and the application of artificial intelligence. He has published over 180 SCI-indexed journal articles and received several international honors, including the Best Free Paper Award (APVRS, 2018), Best Video Award (APVRS, 2019), and Best Free Paper Award (APAO, 2021). Dr. Hsieh has served as faculty at numerous international congresses, including the Retina World Congress, APAO, and APVRS. As the inventor of the AI diagnostic platforms VeriSee DR and VeriSee AMD, he has advanced the application of artificial intelligence in ophthalmology.

Prof. Arief S. Kartasasmita, M.D., Ph.D. is a vitreoretinal surgeon and academic leader from Universitas Padjadjaran and Cicendo Eye Hospital, Bandung, Indonesia. He earned his M.D. in 1996 and completed his residency in ophthalmology in 2004 at Universitas Padjadjaran, followed by a clinical fellowship in vitreoretina at the Nijmegen Eye Institute, The Netherlands. He later obtained his Ph.D. in Genetic Ophthalmology from Juntendo University, Tokyo, in 2011, focusing on retinal degenerative diseases.
He has dedicated over two decades to clinical practice, teaching, and research in ophthalmology, and has been Professor of Ophthalmology since 2018. His scholarly contributions include numerous publications on diabetic retinopathy, retinal detachment, ocular trauma, genetic retinal disorders, and surgical innovations. Internationally, he has been invited to speak at leading ophthalmology congresses such as APAO, Euretina, and APVRS, sharing expertise in vitreoretinal surgery and retinal disease management.
In addition to his academic and clinical work, Prof. Kartasasmita has held prominent leadership positions at Universitas Padjadjaran, including Dean of the Faculty of Medicine and Vice Rector, and since 2024 serves as Rector of the university. He is also President of the Indonesian Vitreoretina Society and the Indonesian Society of Electrophysiology on Vision. Through his leadership, teaching, and research, he continues to play a pivotal role in advancing ophthalmology in Indonesia and contributing to the global retina community.

Dr. Cecilia S. Lee is Professor of Ophthalmology at Washington University in St. Louis, where she focuses on oculomics-using Big Data, retinal imaging and artificial intelligence to study systemic health, Alzheimer’s disease and related dementias, diabetes, and healthy aging. She leads several large, NIH-funded, multi-institutional initiatives, including the Eye ACT study and AI-READI project, and has authored over 170 peer-reviewed publications. Dr. Lee is an advocate for open science and building AI-ready biomedical datasets to advance precision health.

Bart Peter LEROY is an ophthalmologist and clinical geneticist specialised in inherited eye disorders. He is involved in phenotyping and genotyping studies and gene therapy studies. He was part of the team that brought voretigene neparvovec (Luxturna®), the first gene therapy for RPE65-IRD to market. He is (co-)recipient of 33 scientific grants. Bart is Head of Department of Ophthalmology and Staff Member at the Center for Medical Genetics at Ghent University Hospital. He is residency programme director for ophthalmology at Ghent University Hospital/Ghent University. He is also Chair and Full Professor of Ophthalmology and Ophthalmic Genetics at Ghent University, Ghent, Belgium.
Also, Bart is Executive Vice-President of the International Society for Genetic Eye Diseases & Retinoblastoma (ISGEDR), Board Member for Inherited Retinal Diseases of the European Society of Retina Specialists (EURETINA), Board Member of the Société de la Génétique Ophtalmologique Francophone (SGOF), Working Group Leader for Retinal Diseases of the European Network for Rare Eye Diseases (ERN-EYE), President of the Flemish Network for Rare Eye Diseases and Secretary General of the Belgian Fund for Research in Ophthalmology (FRO).
He is (co-)author of 237 peer reviewed publications and has given over 600 presentations on genetic eye diseases all over the World.

Wu Liu, MD., Ph.D., is professor and doctoral supervisor of Ophthalmology of Beijing Tongren Hospital Eye Center, Capital Medical University. He serves as a member on Standing Committee and Secretary-General of Chinese Ophthalmologist Association, President of Ophthalmology Branch of China-Japan Medical Science and Technology Exchange Association, Vice Chairman of Ophthalmology Branch of China National Health Association, member on Standing Committee of Ophthalmology committee of China Health Care and International Exchange Promoting Association, and member on Standing Committee of Eye Care Technology Professional Committee of China Association of Traditional Chinese Medicine. He is also an international member of American Society of Retina Specialists (ASRS) since 2003.
Dr. Liu’s clinical practice and research is mainly on vitreo-retinal disease, especially focus on macular diseased, both surgically and medically. He has published more than 120 peer-reviewed papers as the first or correspondence author in Chinese and English. He has translated and published the first Chinese version of Steve Charles’s Vitreous Microsurgery, Fourth edition. His researches was funded by Beijing Natural Science Foundation and National Natural Science Foundation of China. He has lectured in many Chinese and international ophthalmologic meetings, including as invited speaker in Vail Vitrectomy from 2000 to 2022.

Noemi Lois is a Professor of Ophthalmology at Queens University and an Honorary Consultant Ophthalmologist and Vitreoretinal Surgeon at the Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK. After having obtained her medical degree, Noemi did her Residency in Ophthalmology and PhD degree in Spain and then completed fellowships in 1) Ocular Oncology at Wills Eye Hospital, Philadelphia, with Drs Jerry and Carol Shields, 2) Medical Retina at Moorfields Eye Hospital, London, with Prof Alan Bird, and 3) Vitreoretinal Surgery at The Royal Liverpool University Hospital, Liverpool, with Prof David Wong. Noemi then moved to Aberdeen, Scotland, where she worked as full time Consultant Ophthalmic Surgeon for 13 years and then joined Queens University, Belfast, in 2013 where she has been leading a programme of preclinical and clinical research focused on complications of diabetic retinopathy and vitreoretinal surgery. This programme of research extends from pathogenic mechanisms of disease and risk stratification to new therapies, including determining the most cost-effective therapeutic alternatives for this disease.
Noemi has published over 170 articles in peer review journals (Scopus h-index 48), 13 book chapters and is editor of 3 textbooks, one is on its second edition. Noemi is an ad-hoc referee for numerous peer-review journals and funding bodies and has given numerous lectures as guest speaker at national and international meetings in the UK and aboard (China, Denmark, Germany, India, Indonesia, Ireland, Italy, Japan, Malaysia, Mexico, Pakistan, Singapore, South Africa, Spain, Switzerland and the USA). Noemi is editorial board member for several journals including the Cochrane Eyes and Vision Group. Noemi participated, as a member of the Evidence Review Group, in 10 Single Technology Appraisals for the UK National Institute of Health and Care Excellence (NICE) on new therapies for retinal diseases. She was awarded the King James IV Professorship by the Royal College of Surgeons of Edinburgh in 2024 and delivered the corresponding lecture at the Annual Meeting of the Royal College of Ophthalmologists. She delivered the Meyer-Schwickerath Lecture at the 36th International Congress of German Ophthalmic Surgeons (DOC) in Nuremberg in 2024, and the Mila Oh’s Memorial Lecture at the 2025 annual meeting of the Canadian Retina Society.
Noemi has been Chief Investigator of several publicly funded multi-centre trials, including FILMS, on surgical techniques for macular hole (funded by the Chief Scientist Office, Scotland - Lois N et al. Invest Ophthalmol Vis Sci. 2011;52(3):1586-1592), DIAMONDS, on laser surgery for diabetic macular oedema (funded by the Health Technology Assessment of the National Institute for Health and Care Research, HTA-NIHR - Lois N et al. Trials. 2019;20(1):122; Lois N et al. Ophthalmology. 2023 Jan;130(1):14-27; Lois N et al. Health Technol Assess. 2022 Dec;26(50):1-86) and EMERALD, on multimodal imaging and new pathways of care for people with complications of diabetic retinopathy (funded by the NIHR HTA – Lois N et al. BMJ Open. 2019;9(6):e027795; Lois N et al. Health Technol Assess. 2021 May;25(32):1-104; Lois N et al. Ophthalmology. 2021 Apr;128(4):561-573; Maredza M, Mistry H, Lois N, et al. Br J Ophthalmol. 2022 Nov;106(11):1549-1554; Prior L, Lois N; EMERALD Study Group. Eye 2023;37:1155-1159). Noemi is co-lead of RECOGNISED, a multicentric consortium investigating diabetes, cognitive impairment and dementia, funded by the EU Horizon 2020, and has just recently received HTA-NIHR-support to conduct two large UK-wide randomized clinical trials which will commence this year: DAME, which will compare clinical effectiveness, cost-effectiveness, patient experience and acceptability of anti-VEGF therapies versus combined anti-VEGF therapy and subthreshold micropulse laser (SML) for people with severe diabetic macular oedema, with SML applied once central retinal thickness goes below 400 microns following anti-VEGFs; and COMBAT: To determine clinical and cost-effectiveness, safety and patient experience and acceptability of phacovitrectomy, compared with vitrectomy and subsequent cataract surgery (if/when needed), for non-highly myopic phakic rhegmatogenous retinal detachment, and to set basis for its implementation.

MBBS - Madras Medical College, University of Madras, Chennai, 1980
DO(Ophthalmology)- University of Madras, Chennai, 1984
Fellowship in Retina & Vitreous Surgery (F.R.V.S)- Sankara Nethralaya, Chennai, 1985
F.A.I.C.O. - Fellow of All India Collegium of Ophthalmology, 2012
DSc (Honoris Causa) - Saveetha University, Chennai, 2017
FRCS (Ophthalmology), Glasgow - Fellow Of Royal College Of Physicians And Surgeons, Glasgow, 2018
FELAS - Fellow of European Latino American Society of Ophthalmology, 2019
FICO - Fellow International Council of Ophthalmology
POSITIONS HELD IN NATIONAL & INTERNATIONAL ORGANIZATIONS
Maharashtra Ophthalmological Society (MOS) Advisor (2022-2023), Chairman - Diabetic Retinopathy (2022), President (2007-2008), Chairman - Scientific Committee (2002-2006), Secretary (1998), Chief Editor of Blink Newsletter
International Council of Ophthalmology (ICO) Treasurer (2022-Present), Board of Trustee (2018-2020)
AIOS National Committee For Dr Awareness And Screening
Chairman (2019-2023)
All India Ophthalmological Society (AIOS)
Immediate Past President (2020-2021),
President (2019-2020), President Elect (2018-2019), Vice President (2017-2018).
All India Ophthalmological Society (AIOS) Chairman, Academic Research Committee (2008- 2011), Chairman, Scientific Committee (2002-2008), Member, Scientific Committee (1992-1998).
Asia Pacific Ophthalmic Trauma Society (APOTS)
President (2012-2023), Hon. Secretary (2012).
Global Eye Genetic Consortium (GEGC)
Secretary General (2015-Present)
Asian Eye Genetic Consortium
Secretary General (Present)
Sankara Nethralaya Alumni
Hon. President (2010-Present)
Tele Ophthalmic Society of India (TOSI)
President (2021-Present)
Eye Cancer Society of India (ECSI)
President (2022-Present)
ARVO Global Mentorship Program
Major Milestones
More than 300 Publications in National and International Journal
90+ Medical and Non Medical Awards for my Contribution in Ophthalmology
2500+ Presentations in National and International Conferences
60,000+ Exclusive Vitreous and Retinal Surgeries
Trained more than 68 Vitreo-retinal surgeons across the globe

Dr. Carl D. Regillo is Professor of Ophthalmology at Thomas Jefferson University, Chief of the Retina Service of Wills Eye Hospital and Founder of the Wills Eye Clinical Retina Research Unit in Philadelphia. He received his medical degree from Harvard Medical School and performed his ophthalmology residency and vitreoretinal fellowship at Wills Eye Hospital. He has authored over 300 publications along with over 50 book chapters and 9 major books. He has been an investigator on numerous major clinical trials developing new medical and surgical treatments for retinal disorders such as macular degeneration and diabetic retinopathy. He is invited to lecture worldwide and serves on the scientific editorial board for several top ophthalmology peer-reviewed journals. As a recognized leader in the field, he is a recipient of the many local, national, and international awards including American Academy of Ophthalmology Achievement, Senior Achievement, Secretariat, and Lifetime Achievement Awards and the American Society of Retinal Specialists Honor, Senior Honor, Presidential, and Founders Awards. He was charter inductee of the Retina Hall of Fame and named in the Ophthalmologist Power List of the top 100 most influential ophthalmologists in the world. He was also listed among the top 150 ophthalmologists in the US by Newsweek.

Kourous A. Rezaei, M.D., is an internationally recognized expert in the treatment of medical and surgical vitreoretinal diseases. He is associate professor of ophthalmology and director of vitreoretinal fellowship at Rush University Medical Center and is a senior partner at the Illinois Retina Associates in Chicago. Dr. Rezaei is a distinguished inductee of the Retina Hall of Fame and is listed in the Illinois Top Doctors. He is the founder of ChannelR (www.channelr.net) and course director of RETINAWS and Formula Retina. He is a founding member of Retina World Congress, serving on its board as President, is on the board of EURETINA, and is on the organizing committee of the Florence Retina Congress (FLORetina). He had served on the board of the American Society of Retina Specialists (ASRS) and as editorial board member for Investigative Ophthalmology and Visual Science (IOVS), Retina Times (ASRS), Retina Today (BMC), and Eyetube.

Dr. Lucia Sobrin is the Charles Edward Whitten Professor of Ophthalmology at Harvard Medical School and Associate Chief for Clinical Data Science at the Massachusetts Eye and Ear Infirmary. She is a practicing uveitis and retina specialist at the Infirmary and serves as the Director of the Morse Laser and Infusion Center, Associate Director of the Retina Service, and Co-Director of the Uveitis Fellowship. Her clinic focuses primarily on posterior segment uveitis and autoimmune retinopathy. Her primary research interests are in the epidemiology and genetics of diabetic retinopathy and uveitis.

Daniele Tognetto is Full Professor of Ophthalmology and Director of the Eye Clinic at the University of Trieste, where he has performed over 20,000 surgical procedures on cataract, retina, cornea, and glaucoma; graduated in Medicine and Surgery with honors in 1987 and specialized in Ophthalmology with honors in 1991, he has progressed from researcher to full professor, leading the residency program and training new generations of surgeons; his research focuses on vitreoretinal and cataract surgery, intraocular lenses, biomaterials, and artificial intelligence applications in ophthalmology, resulting in more than 160 peer-reviewed publications and several scientific book chapters; he has been an invited speaker at numerous international congresses and has performed over 40 live surgeries at major scientific events; past President of the Italian Society of Cataract and Refractive Surgery (AICCER) and formerly President of the Italian Society of Vitreoretinal Surgeons (GIVRE) and the Triveneta Ophthalmology Society (SOT), he is also an active member of leading international ophthalmic societies; throughout his career he has received prestigious awards.

Dr Andrew Tsai is a Senior Consultant in the Surgical Retina Department at the Singapore National Eye Centre (SNEC) and Clinical Associate Professor with the SingHealth Duke-NUS Ophthalmology & Visual Sciences Academic Clinical Programme.
He completed specialist accreditation in Ophthalmology in 2016, and is a Fellow of the Royal College of Ophthalmologists (UK) and the Academy of Medicine, Singapore. Dr Tsai received advanced training in vitreoretinal surgery and pediatric retinal diseases in the US and Taiwan. His practice includes adult and pediatric vitreoretinal surgery, medical retina, and cataract care. His research interest includes myopic traction maculopathy and pediatric retinal vascular diseases.

Professor Tom H. Williamson is a leading vitreoretinal surgeon based at St Thomas’ Hospital, London, with over 30 years of experience treating complex retinal disorders. He graduated in medicine from the University of Glasgow in 1984 and trained in ophthalmology across Glasgow, Aberdeen, Cambridge and London before specialising in vitreoretinal surgery.
Clinically, he has one of the largest individual surgical case volumes worldwide, having performed over 20,000 vitreoretinal operations. His expertise covers retinal detachment repair, macular hole and epiretinal membrane surgery, diabetic retinopathy, trauma, and complex cataract complications. He practices within the NHS at St Thomas’ and privately at the London Lauriston Clinic, Centre for Sight (Oxshott), and the London Clinic.
Alongside his surgical career, Professor Williamson is Visiting Professor in Biological Sciences and Engineering at the University of Surrey and Clinical Lecturer at King’s College London. He has authored more than 250 publications and several major textbooks, including the standard reference Vitreoretinal Surgery, now in its third edition. He has trained around 50 fellows, many of whom now serve as consultants worldwide.
He has held senior leadership roles, including President of the British & Eire Vitreoretinal Society, Programme Director for ophthalmology training in London, and director of the Consultants Eye Surgeons Partnership (South London). Internationally, he has served on the board of the Vail Vitrectomy Meeting and been faculty at Euretina and Floretina and ESASO.
Professor Williamson co-founded the Eyehope charity and has supported Fight for Sight and the World Sight Foundation. More recently, he established Infinite Medical Ventures, developing AI-driven ophthalmic diagnostic tools.
Widely recognised for his surgical skill, research and teaching, Professor Williamson remains at the forefront of innovation in vitreoretinal care, combining extensive clinical experience with a commitment to advancing patient outcomes globally.

Prof Wong completed medical school at the National University of Singapore (NUS), and obtained a MPH and PhD from Johns Hopkins University, USA. He completed residency clinical training in ophthalmology at the Singapore National Eye Centre, with retinal fellowships at the University of Wisconsin, Madison, USA and the University of Sydney, Australia. Prof Wong is a physician-scientist-leader, and an internationally renowned ophthalmologist and retinal specialist.
In 2021, Prof Wong was appointed the Founding head and Senior Vice-Chancellor of Tsinghua Medicine, a new academic health system integrating multiple Schools and teaching hospitals, based at Tsinghua University, Beijing, China. For his contribution, he was awarded the Beijing Great Wall Friendship Award in 2024, the highest award for major contributions to China as a foreigner national, given once every 3 years.
Prof Wong has held prior senior academic and clinical leadership appointments in Singapore and Australia. From 2014 to 2021, Prof Wong was Arthur Lim Professor of Ophthalmology and Medical Director at SNEC. During this time, Prof Wong was concurrently Deputy Group CEO (Research and Education) at SingHealth and Vice-Dean at Duke-NUS Medical School. Prior to these, Prof Wong was Group Director Research, SingHealth, Executive Director, Singapore Eye Research Institute (SERI), Chair of Ophthalmology at NUS and Chair of Ophthalmology at University of Melbourne, Australia.
Prof Wong is a physician-scientist-innovator who has conducted broad-based research on the development and application of artificial intelligence (AI) and digital technology in medicine and healthcare, particularly to the screening, detection and prevention of eye diseases. He has published >1500 papers, including papers in the New England Journal of Medicine, Lancet, JAMA and Nature Medicine. He has a H-index of >220, is a multi-year Highly Cited Researcher (2018, 2020-25), given >500 invited plenary and symposium lectures, received >US$100 million in grant funding.

Prof Wong serves or has previously served on Editorial Boards of Lancet Digital Health, NEJM-AI, JAMA-Ophthalmology, Diabetes Care, amongst many others. He serves or has served on Boards, Councils or Trustees of the National Medical Research Council Singapore, the International Council of Ophthalmology, the Asia Pacific Academy of Ophthalmology (APAO), the Asia Pacific Vitreo-Retinal Society (APVRS), the Macula Society, the Academy of Medicine Singapore, the Singapore Medical Council and other bodies. He is the current elected Board Trustee of the Association for Research in Vision and Ophthalmology (ARVO). He was past President of the College of Ophthalmologists, Singapore, and the current President of the Asia-Pacific Ocular Imaging Society (APOIS). He is an elected member of the Academia Ophthamological Internationalis (AOI) and the American Ophthalmological Society (AOS).
Prof Wong has been recognized with numerous awards, including the Commonwealth Health Minister’s Award, the Arnall Patz Medal (Macula Society), the Alcon Research Institute Award, the Jose Rizal Medal (APAO), the Friedenwald Award (ARVO). He has received Singapore’s President’s Science Award and President’s Science and Technology Award.
He is an elected Fellow of four academies: the Singapore National Academy of Sciences, the US National Academy of Medicine, the Royal Society in UK and the Australian Academy of Health and Medical Sciences.

Professor Seung-Young Yu is a vitreoretinal surgeon and ophthalmologist, currently serving as Professor and Chair of Ophthalmology at Kyunghee University Hospital.
She obtained her medical degree, Master’s, and Doctorate from Kyunghee University School of Medicine. She completed fellowships in Clinical Retina at Kyunghee University Hospital and in Research Retina at Harvard Medical School, Massachusetts Eye and Ear Infirmary, and was also a Visiting Scholar at Stanford University, Byers Eye Institute.
Prof. Yu specializes in retinal imaging - including OCT, OCT angiography, and fundus autofluorescence - in retinal diseases such as AMD, CSC, and diabetic retinopathy. She has published over 100 peer-reviewed SCI journal articles and is a frequent invited speaker at international ophthalmology meetings.
Her contributions have been recognized with the Asia-Pacific Academy of Ophthalmology Achievement and Distinguished Service Awards. She currently serves as Vice President of the Asia-Pacific Vitreo-Retina Society, a Board Member of the American Society of Retina Specialists, and a Board Member of the International Retinal Imaging Society.

Professor Martin S. Zinkernagel is Chair of the Department of Ophthalmology at the University Hospital of Bern, Switzerland and director of the internationally renowned Bern Photographic Reading Center at the University of Bern. Born Australian in Canberrra ACT he moved back to Switzerland via La Jolla, CA, where he attended school in Zurich. He earned his M.D from the University of Zurich and a PhD in ocular immunology and gene therapy from the University of Western Australia. Main clinical interests encompass vitreoretinal surgery, medical retina, ocular traumatology and cataract surgery. His main research interests are retinal imaging, ophthalmic data analysis using artificial intelligence and the influence of the gut microbiome in retinal disease and immunology of the ocular surface. Basic science interests are ocular immunology and inflammation. He currently serves as general secretary and member of the board of EURETINA, board member of EUEYE and is editor in chief of Ophthalmologica. He is member of various ophthalmology societies around the world.